Literature DB >> 15930161

Gene therapy of pituitary diseases.

Eun Jig Lee1, J Larry Jameson.   

Abstract

Despite a stuttering course, gene therapy continues to provide a potential treatment avenue for many human diseases, including cancer and various inherited disorders. Gene therapy is also attractive for the treatment of local, benign disorders, such as pituitary adenomas. Advances in technology have focused on modifying existing viral vectors and developing targeted expression of therapeutic genes in an effort to achieve efficacy with minimal toxicity. Gene therapy also offers innovative strategies for treating hypopituitarism by replacing hormones such as growth hormone (GH) and vasopressin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15930161     DOI: 10.1677/joe.1.06023

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  3 in total

Review 1.  Medical treatment of prolactinomas.

Authors:  Annamaria Colao; Silvia Savastano
Journal:  Nat Rev Endocrinol       Date:  2011-03-22       Impact factor: 43.330

Review 2.  Cancer nanotechnology: emerging role of gold nanoconjugates.

Authors:  Rachel A Kudgus; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  Anticancer Agents Med Chem       Date:  2011-12       Impact factor: 2.505

Review 3.  Precision Therapy in Acromegaly Caused by Pituitary Tumors: How Close Is It to Reality?

Authors:  Cheol Ryong Ku; Vladimir Melnikov; Zhaoyun Zhang; Eun Jig Lee
Journal:  Endocrinol Metab (Seoul)       Date:  2020-06-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.